A Lethal Case of Acute Exacerbation of Rheumatoid Arthritis - Related Interstitial Lung Disease Induced by the COVID Vaccine.

Rayan Mohamad, Rami Hallak, Imad Bou Akl, Hisham Bou Fakhreddine

Abstract readCase Reports

In one paragraph

Article in Respiratory medicine case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rayan MohamadPulmonary, Critical Care, and Sleep Medicine Division, Department of Internal Medicine, American University of Beirut Medical Center, Riad El-Solh, 1107 2020, Beirut, Lebanon.

Rami HallakPulmonary, Critical Care, and Sleep Medicine Division, Department of Internal Medicine, American University of Beirut Medical Center, Riad El-Solh, 1107 2020, Beirut, Lebanon.

Imad Bou AklPulmonary, Critical Care, and Sleep Medicine Division, Department of Internal Medicine, American University of Beirut Medical Center, Riad El-Solh, 1107 2020, Beirut, Lebanon.

Hisham Bou FakhreddinePulmonary, Critical Care, and Sleep Medicine Division, Department of Internal Medicine, American University of Beirut Medical Center, Riad El-Solh, 1107 2020, Beirut, Lebanon.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interstitial lung disease (ILD) exacerbation is a serious condition that can have a high morbidity and mortality. Identifying the triggers of ILD exacerbations is very challenging. Several case reports described COVID-19 vaccine-induced exacerbation of underlying interstitial lung disease, namely idiopathic interstitial pneumonias. The clinical implications of this adverse effect is underrecognized. We are reporting a case of fatal respiratory failure in a patient with rheumatoid arthritis Interstitial Lung disease few days following the second dose of COVID vaccine. Identifying risk factors of this complication is of utmost importance to aid in the rapid recognition and early initiation of treatment.

Indexed as

COVID-19 vaccineDrug induced interstitial lung diseaseInterstitial lung disease exacerbationRheumatoid arthritis-interstitial lung disease

Identifiers

PMID39822332

DOI10.1016/j.rmcr.2023.101959

PMCPMC11736164

What OpenQuestion holds

Textmetadata

LicenceCC BY-NC-ND

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.